Meet with our product experts in one-on-one virtual sessions

Set Up a Meeting
Conexión rápida

Nota informativa

Remdesivir

2021

White Paper: Redyx: Remdesivir formulation developed at Dr. Reddy’s under the license from Gilead

Whitepaper : Dr.Reddy's 2 DG- A promising treatment in hospitalized COVID-19 patients

2021

Whitepaper : Dr.Reddy's 2 DG- A promising treatment in hospitalized COVID-19 patients

Techsheet: Dr.Reddy's Lenvatinib API offerings

2021

Techsheet: Dr.Reddy's Lenvatinib API offerings

Bempedoic acid - a near term launch opportunity for generic pharma manufacturers

2021

Bempedoic acid - a near term launch opportunity for generic pharma manufacturers

ROXADUSTAT - a multipronged development strategy

2021

ROXADUSTAT - a multipronged development strategy

Dr.Reddy's Apremilast API and finished formulation offerings.

2021

Dr.Reddy's Apremilast API and finished formulation offerings.

Dr. Reddy’s Fosaprepitant API offerings

2021

Dr. Reddy’s Fosaprepitant API offerings

Apixaban API – ready-to-compress granules and finished dosage forms

2021

Apixaban API – ready-to-compress granules and finished dosage forms

Apalutamide API – an attractive NCE-1 opportunity for generic pharma companies

2021

Apalutamide API – an attractive NCE-1 opportunity for generic pharma companies

Colloidal Iron Complex Formulations – Understanding and Developing the Process

2021

Colloidal Iron Complex Formulations – Understanding and Developing the Process

Rivaroxaban from Dr.Reddy’s: Full basket offerings of API and Finished formulations

2021

Rivaroxaban from Dr.Reddy’s: Full basket offerings of API and Finished formulations

Dr. Reddy's Mirabegron API offering in both alpha and amorphous form

2021

Dr. Reddy's Mirabegron API offering in both alpha and amorphous form

Palbociclib – how a novel process development approach provides IP advantages

2021

Palbociclib – how a novel process development approach provides IP advantages

Dr. Reddy's Elagolix API offering leverages a well rounded Quality by Design approach

2020

Dr. Reddy's Elagolix API offering leverages a well rounded Quality by Design approach

Sacubitril/Valsartan (LCZ696) – Bringing yet another advantage through innovative API offerings

2020

Sacubitril/Valsartan (LCZ696) – Bringing yet another advantage through innovative API offerings

Dr. Reddy’s Flow Chemistry experts share their perspectives in panel discussion of Chemistry Today

2020

Dr. Reddy’s Flow Chemistry experts share their perspectives in panel discussion of Chemistry Today

A closer look on how Dr. Reddy's met the stringent regulatory requirement of genotoxic impurities in Ranolazine

2020

A closer look on how Dr. Reddy's met the stringent regulatory requirement of genotoxic impurities in Ranolazine

Famotidine and Nizatidine APIs: NDMA controlled, customized particle distribution, supply chain security

2020

Famotidine and Nizatidine APIs: NDMA controlled, customized particle distribution, supply chain security

Sugammadex Sodium – The impact of an integrated understanding from API to formulation on injectable formulation success

2020

Sugammadex Sodium – The impact of an integrated understanding from API to formulation on injectable formulation success

Meeting the New Regulatory Requirements in Sartan API Production

2019

Meeting the New Regulatory Requirements in Sartan API Production

Meet with our product experts in one-on-one virtual sessions

Our experts will answer your questions, provide advice, and help you understand our product better

Set Up a Meeting
X

API
Active Pharmaceutical Ingredients

API Supplier of the Year

Global Generics & Biosimilars Awards 2021 winner for 3 consecutive years!

Explore our Products